US Stock MarketDetailed Quotes

CLDX Celldex Therapeutics

Watchlist
  • 37.170
  • +0.810+2.23%
Close Jul 9 16:00 ET
  • 37.520
  • +0.350+0.94%
Post 17:41 ET
2.45BMarket Cap-12996P/E (TTM)

Celldex Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Celldex Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

156.00K

-83.87%
EPS(YoY)

-0.56

+9.68%
Analyst Rating

Strong Buy

Jul 9, 2024

Celldex Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 860.000K--
--2024/Q2-- / 854.290K--
--2024/Q1156.000K / 816.670K--
Feb 26, 20242023/Q44.132M / 855.710K--
--2023/Q31.517M / 583.330K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 860.000K--
--2024/Q2-- / 854.290K--
--2024/Q1156.000K / 816.670K--
Feb 26, 20242023/Q44.132M / 855.710K--
--2023/Q31.517M / 583.330K--

Unlock Free Earnings Estimates

Celldex Therapeutics Earnings Reports

  • Celldex Therapeutics | 10-Q: Quarterly report

    May 6 16:13 ET

  • Celldex Therapeutics | 10-K: Annual report

    Feb 26 07:10 ET

  • Celldex Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 16:06 ET

  • Celldex Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 8, 2023 16:06 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 9, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg